247 related articles for article (PubMed ID: 16312558)
1. Effect of oral ciprofloxacin on fecal bacteria in elderly patients.
Höffler U; Grünig F; Brehmer B
J Chemother; 1989 Jul; 1(4 Suppl):617-8. PubMed ID: 16312558
[No Abstract] [Full Text] [Related]
2. Comparative in vitro study of the antibacterial effect of cefotetan against gram-positive and gram-negative aerobic and anaerobic strains from fresh clinical isolates.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Jun; 6(2 Suppl):92-3. PubMed ID: 3509542
[No Abstract] [Full Text] [Related]
3. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
[TBL] [Abstract][Full Text] [Related]
4. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oral ciprofloxacin as selective intestinal decontaminant in cirrhosis.
Borzio M; Salerno F; Saudelli M; Galvagno D; Piantoni L; Fragiacomo L
Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):262-6. PubMed ID: 9646219
[TBL] [Abstract][Full Text] [Related]
6. In vitro comparison of ciprofloxacin to parenteral antibiotics.
Speciale A; Caccamo F; Nicoletti G
J Chemother; 1989 Jul; 1(4 Suppl):154-6. PubMed ID: 16312349
[No Abstract] [Full Text] [Related]
7. Evaluation of the mandibular third molar pericoronitis flora and its susceptibility to different antibiotics prescribed in france.
Sixou JL; Magaud C; Jolivet-Gougeon A; Cormier M; Bonnaure-Mallet M
J Clin Microbiol; 2003 Dec; 41(12):5794-7. PubMed ID: 14662986
[TBL] [Abstract][Full Text] [Related]
8. Tigecycline: a novel glycylcycline antibiotic.
Zhanel GG; Karlowsky JA; Rubinstein E; Hoban DJ
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):9-25. PubMed ID: 16441206
[TBL] [Abstract][Full Text] [Related]
9. 2-Hydroxyisocaproic acid (HICA): a new potential topical antibacterial agent.
Sakko M; Tjäderhane L; Sorsa T; Hietala P; Järvinen A; Bowyer P; Rautemaa R
Int J Antimicrob Agents; 2012 Jun; 39(6):539-40. PubMed ID: 22483561
[No Abstract] [Full Text] [Related]
10. In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent.
Kwon AR; Min YH; Ryu JM; Choi DR; Shim MJ; Choi EC
J Antimicrob Chemother; 2006 Sep; 58(3):684-8. PubMed ID: 16873394
[TBL] [Abstract][Full Text] [Related]
11. [Identification of non-sporoforming anaerobic bacteria in urine cultures and their significance].
Lugo G; García-García G
Rev Latinoam Microbiol; 1985; 27(3):183-90. PubMed ID: 4095405
[No Abstract] [Full Text] [Related]
12. Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.
Scully BE; Jules K; Chin NX; Neu HC
Am J Med; 1987 Apr; 82(4A):336-8. PubMed ID: 3578324
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.
Fernandez-Hidalgo N; Almirante B; Calleja R; Ruiz I; Planes AM; Rodriguez D; Pigrau C; Pahissa A
J Antimicrob Chemother; 2006 Jun; 57(6):1172-80. PubMed ID: 16597634
[TBL] [Abstract][Full Text] [Related]
14. Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract.
Karp JE; Merz WG; Hendricksen C; Laughon B; Redden T; Bamberger BJ; Bartlett JG; Saral R; Burke PJ
Scand J Infect Dis Suppl; 1986; 48():66-78. PubMed ID: 3535055
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory evaluation of different dosage forms of baneocin for the treatment of wound infection.
Blatun LA; Zhukov AO; Amiraslanov IuA; Terekhova RP; Agafonov VA; Askerov NG; Malina VA; Ushakov AA; Ivanov AP; Fedotov SV; Pechetov AA; Tertitskaia AB
Khirurgiia (Mosk); 2009; (9):59-65. PubMed ID: 19824200
[No Abstract] [Full Text] [Related]
16. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
Raja NS
J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
[TBL] [Abstract][Full Text] [Related]
17. Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Bedenic B; Topic M; Budimir A; Bubonja M
Chemotherapy; 2006; 52(6):293-7. PubMed ID: 17008781
[TBL] [Abstract][Full Text] [Related]
18. Follow-up therapy with ciprofloxacin in severe infection, an alternative to parenteral treatment.
Bassaris HP; Chrysanthopoulos CJ; Skouelis AT; Starakis JC
J Chemother; 1989 Jul; 1(4 Suppl):676-7. PubMed ID: 16312588
[No Abstract] [Full Text] [Related]
19. Pridominant isolates of urinary tract pathogens and their antimicrobial susceptiblity patterns in Gondar University Teaching Hospital, nothwest Ethiopia.
Tessema B; Kassu A; Mulu A; Yismaw G
Ethiop Med J; 2007 Jan; 45(1):61-7. PubMed ID: 17642159
[TBL] [Abstract][Full Text] [Related]
20. [Resistance of causative agents of uncomplicated urinary tract infections in Russia].
Rafal'skiĭ VV; Strachunskiĭ LS; Babkin PA; Valenskaia VS; Gabbasova LA; Dmitrieva OB; Emel'ianova IV; Krupin VN; Malev IV; Petrov SB; Rokhlikov IM; Furletova NM; Khaĭrullov AS
Urologiia; 2006; (5):34-7. PubMed ID: 17444150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
